DE3883606T2 - Verwendung von Fluoxetin zur Behandlung des Diabetes. - Google Patents
Verwendung von Fluoxetin zur Behandlung des Diabetes.Info
- Publication number
- DE3883606T2 DE3883606T2 DE88303930T DE3883606T DE3883606T2 DE 3883606 T2 DE3883606 T2 DE 3883606T2 DE 88303930 T DE88303930 T DE 88303930T DE 3883606 T DE3883606 T DE 3883606T DE 3883606 T2 DE3883606 T2 DE 3883606T2
- Authority
- DE
- Germany
- Prior art keywords
- fluoxetine
- treat diabetes
- diabetes
- treat
- mammals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4550987A | 1987-05-04 | 1987-05-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3883606D1 DE3883606D1 (de) | 1993-10-07 |
DE3883606T2 true DE3883606T2 (de) | 1994-01-20 |
Family
ID=21938301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE88303930T Expired - Fee Related DE3883606T2 (de) | 1987-05-04 | 1988-04-29 | Verwendung von Fluoxetin zur Behandlung des Diabetes. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0294028B1 (de) |
JP (1) | JP2721507B2 (de) |
KR (1) | KR880013555A (de) |
AT (1) | ATE93721T1 (de) |
AU (1) | AU596296B2 (de) |
DE (1) | DE3883606T2 (de) |
DK (1) | DK238588A (de) |
ES (1) | ES2058272T3 (de) |
HK (1) | HK19595A (de) |
PH (1) | PH23901A (de) |
ZA (1) | ZA883115B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2039103A1 (en) * | 1990-03-29 | 1991-09-30 | David Wayne Robertson | Improvements in and relating to the selective occupation of serotonin 1c receptors |
US5589511A (en) * | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
US7034059B2 (en) | 2001-07-02 | 2006-04-25 | Sepracor Inc. | Methods of using norfluoxetine |
SI2316456T1 (sl) | 2003-04-29 | 2017-10-30 | Orexigen Therapeutics, Inc. | Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion |
EP2135603B1 (de) | 2005-11-22 | 2013-01-02 | Orexigen Therapeutics, Inc. | Zusammensetzungen und Verfahren zur Erhöhung der Insulinsensitivität |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
KR101735466B1 (ko) | 2006-11-09 | 2017-05-15 | 오렉시젠 세러퓨틱스 인크. | 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형 |
KR20150082689A (ko) | 2006-11-09 | 2015-07-15 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
CA2725930A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
CN102724878A (zh) | 2010-01-11 | 2012-10-10 | 奥雷西根治疗公司 | 在重度抑郁症患者中提供体重减轻疗法的方法 |
DK3730132T3 (da) | 2012-06-06 | 2022-08-08 | Nalpropion Pharmaceuticals Llc | Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko |
US20150174083A1 (en) | 2012-07-31 | 2015-06-25 | Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi | Use of fluoxetine for increasing meat and milk production |
EA201590044A1 (ru) | 2012-07-31 | 2015-09-30 | Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. | Применение флуоксетина у животных |
US8969371B1 (en) | 2013-12-06 | 2015-03-03 | Orexigen Therapeutics, Inc. | Compositions and methods for weight loss in at risk patient populations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626549A (en) * | 1974-01-10 | 1986-12-02 | Eli Lilly And Company | Treatment of obesity with aryloxyphenylpropylamines |
US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
US4590213A (en) * | 1983-04-08 | 1986-05-20 | Eli Lilly And Company | Anti-anxiety method |
CA1267092A (en) * | 1985-02-25 | 1990-03-27 | Martin D. Hynes | Analgesic composition containing codeine |
-
1988
- 1988-04-29 ES ES88303930T patent/ES2058272T3/es not_active Expired - Lifetime
- 1988-04-29 AT AT88303930T patent/ATE93721T1/de not_active IP Right Cessation
- 1988-04-29 PH PH36859A patent/PH23901A/en unknown
- 1988-04-29 EP EP88303930A patent/EP0294028B1/de not_active Expired - Lifetime
- 1988-04-29 DE DE88303930T patent/DE3883606T2/de not_active Expired - Fee Related
- 1988-05-02 ZA ZA883115A patent/ZA883115B/xx unknown
- 1988-05-02 JP JP63109838A patent/JP2721507B2/ja not_active Expired - Lifetime
- 1988-05-03 KR KR1019880005132A patent/KR880013555A/ko not_active Application Discontinuation
- 1988-05-03 AU AU15533/88A patent/AU596296B2/en not_active Ceased
- 1988-05-03 DK DK238588A patent/DK238588A/da not_active Application Discontinuation
-
1995
- 1995-02-09 HK HK19595A patent/HK19595A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0294028B1 (de) | 1993-09-01 |
DK238588D0 (da) | 1988-05-03 |
AU596296B2 (en) | 1990-04-26 |
KR880013555A (ko) | 1988-12-21 |
JP2721507B2 (ja) | 1998-03-04 |
HK19595A (en) | 1995-02-17 |
EP0294028A2 (de) | 1988-12-07 |
ES2058272T3 (es) | 1994-11-01 |
PH23901A (en) | 1989-12-18 |
JPS63284126A (ja) | 1988-11-21 |
DK238588A (da) | 1988-11-05 |
ZA883115B (en) | 1990-01-31 |
DE3883606D1 (de) | 1993-10-07 |
EP0294028A3 (en) | 1990-05-02 |
ATE93721T1 (de) | 1993-09-15 |
AU1553388A (en) | 1988-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3883606D1 (de) | Verwendung von Fluoxetin zur Behandlung des Diabetes. | |
ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
DE3584013D1 (de) | Zubereitung zur behandlung von psoriasis. | |
DE3878627T2 (de) | Zusammensetzung zur oberflaechenbehandlung von kautschuk. | |
DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
DE3882775D1 (de) | Zusammensetzung zur behandlung von parodontaler krankheit. | |
ATE95694T1 (de) | Verwendung von bezafibrat zur behandlung von diabetes. | |
DE69013999D1 (de) | Siliconkautschukzusammensetzung zur Behandlung von Faserstrukturen. | |
DE3681642D1 (de) | Benzopyran-verbindungen zur behandlung von inkontinenz. | |
ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
DE3680507D1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
DE3781667D1 (de) | Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
PT80152B (de) | Methode zur behandlung des glaukoms vok | |
DE3787954D1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen. | |
DE3686688T2 (de) | Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten. | |
DE3684825D1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
DE3688742D1 (de) | 2,2-diphenoxy-n,n-dimethylaminoaethan zur verbesserung der sauerstoffversorgung des gehirns. | |
DE69232918D1 (de) | Verwendung von Carbachol zur Behandlung verringerter willkürlicher Mobilität | |
ATE81001T1 (de) | Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen. | |
ATE66780T1 (de) | Zubereitung zur behandlung von psoriasis. | |
ATE64683T1 (de) | Zusammensetzung zur behandlung von haemorroiden. | |
ATE46440T1 (de) | Behandlung von praemenstruellen syndromen unter verwendung von triazolobenzodiazepinen. | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
ATE64917T1 (de) | Vorrichtung zur behandlung von erntematerial. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |